Search research articles
Contact Us
Filters
Showing results (41-50 of 135) with videos related to
Page
of 14
Sort By:
American Journal of Hematology
|
September 27, 2025
Venetoclax in Combination With Pediatric-Inspired Chemotherapy in Adults With Newly Diagnosed Acute Lymphoblastic Leukemia: Results of a Phase I Trial
Yannis K Valtis, David Nemirovsky, Andriy Derkach, et al.
Leukemia
|
November 6, 2021
Serum antibody response in patients with philadelphia-chromosome positive or negative myeloproliferative neoplasms following vaccination with SARS-CoV-2 spike protein messenger RNA (mRNA) vaccines
Kathryn E Kozak, Linda Ouyang, Andriy Derkach, et al.
Histopathology
|
April 30, 2024
Multilineage involvement in KMT2A-rearranged B acute lymphoblastic leukaemia: cell-of-origin, biology, and clinical implications
Umut Aypar, Deepika Dilip, Ramya Gadde, et al.
Journal of Racial and Ethnic Health Disparities
|
May 30, 2025
Investigating Disparities in Prescription Drug Use Among Mexican Americans and Non-Hispanic Whites
Maria J Monroy-Iglesias, Gabrielle Zuckerman, Peng Wang, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
November 8, 2013
A hypothesis-driven association study of 28 nuclear-encoded mitochondrial genes with antipsychotic-induced weight gain in schizophrenia
Vanessa F Gonçalves, Clement C Zai, Arun K Tiwari, et al.
European Journal of Haematology
|
October 14, 2024
Pacritinib Response Is Associated With Overall Survival in Myelofibrosis: PERSIST-2 Landmark Analysis of Survival
Helen Ajufo, Jan Philipp Bewersdorf, Claire Harrison, et al.
British Journal of Haematology
|
August 16, 2021
Comparison of venous thromboembolism incidence in newly diagnosed multiple myeloma patients receiving bortezomib, lenalidomide, dexamethasone (RVD) or carfilzomib, lenalidomide, dexamethasone (KRD) with aspirin or rivaroxaban thromboprophylaxis
Katrina Piedra, Tim Peterson, Carlyn Tan, et al.
Leukemia & Lymphoma
|
June 28, 2021
Neutropenia in adult acute myeloid leukemia patients represents a powerful risk factor for COVID-19 related mortality
Maximilian Stahl, Varun Narendra, Justin Jee, et al.
Leukemia Research
|
May 22, 2022
De Novo myelodysplastic syndromes in patients 20-50 years old are enriched for adverse risk features
Zachary D Epstein-Peterson, Barbara Spitzer, Andriy Derkach, et al.
Haematologica
|
September 3, 2021
Diabetes mellitus and risk of plasma cell and lymphoproliferative disorders in 94,579 cases and 368,348 matched controls
Urvi A Shah, Sæmundur Rögnvaldsson, Andriy Derkach, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 135) with videos related to
Sort By:
Page
of 14
American Journal of Hematology
|
September 27, 2025
Venetoclax in Combination With Pediatric-Inspired Chemotherapy in Adults With Newly Diagnosed Acute Lymphoblastic Leukemia: Results of a Phase I Trial
Yannis K Valtis, David Nemirovsky, Andriy Derkach, et al.
Leukemia
|
November 6, 2021
Serum antibody response in patients with philadelphia-chromosome positive or negative myeloproliferative neoplasms following vaccination with SARS-CoV-2 spike protein messenger RNA (mRNA) vaccines
Kathryn E Kozak, Linda Ouyang, Andriy Derkach, et al.
Histopathology
|
April 30, 2024
Multilineage involvement in KMT2A-rearranged B acute lymphoblastic leukaemia: cell-of-origin, biology, and clinical implications
Umut Aypar, Deepika Dilip, Ramya Gadde, et al.
Journal of Racial and Ethnic Health Disparities
|
May 30, 2025
Investigating Disparities in Prescription Drug Use Among Mexican Americans and Non-Hispanic Whites
Maria J Monroy-Iglesias, Gabrielle Zuckerman, Peng Wang, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
November 8, 2013
A hypothesis-driven association study of 28 nuclear-encoded mitochondrial genes with antipsychotic-induced weight gain in schizophrenia
Vanessa F Gonçalves, Clement C Zai, Arun K Tiwari, et al.
European Journal of Haematology
|
October 14, 2024
Pacritinib Response Is Associated With Overall Survival in Myelofibrosis: PERSIST-2 Landmark Analysis of Survival
Helen Ajufo, Jan Philipp Bewersdorf, Claire Harrison, et al.
British Journal of Haematology
|
August 16, 2021
Comparison of venous thromboembolism incidence in newly diagnosed multiple myeloma patients receiving bortezomib, lenalidomide, dexamethasone (RVD) or carfilzomib, lenalidomide, dexamethasone (KRD) with aspirin or rivaroxaban thromboprophylaxis
Katrina Piedra, Tim Peterson, Carlyn Tan, et al.
Leukemia & Lymphoma
|
June 28, 2021
Neutropenia in adult acute myeloid leukemia patients represents a powerful risk factor for COVID-19 related mortality
Maximilian Stahl, Varun Narendra, Justin Jee, et al.
Leukemia Research
|
May 22, 2022
De Novo myelodysplastic syndromes in patients 20-50 years old are enriched for adverse risk features
Zachary D Epstein-Peterson, Barbara Spitzer, Andriy Derkach, et al.
Haematologica
|
September 3, 2021
Diabetes mellitus and risk of plasma cell and lymphoproliferative disorders in 94,579 cases and 368,348 matched controls
Urvi A Shah, Sæmundur Rögnvaldsson, Andriy Derkach, et al.
Page
of 14